Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Multiple Sclerosis Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Robust investment in research and development activities globally
5.1.1.2. Favorable government support to increase the awareness among people
5.1.1.3. Rising incidence of MS in young and elderly people
5.1.2. Restraints
5.1.2.1. Relatively high cost of the drugs
5.1.3. Opportunities
5.1.3.1. Increasing preference for oral drugs such as Copaxone and Tysabri
5.1.3.2. Emerging novel pipeline of drugs by key market players
5.1.4. Challenges
5.1.4.1. Stringent regulatory policies for drug approval
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Multiple Sclerosis Market, by Treatment Modality
6.1. Introduction
6.2. Injectable Agents
6.3. Oral Agents

7. Multiple Sclerosis Market, by Application
7.1. Introduction
7.2. Hospital
7.3. Research

8. Americas Multiple Sclerosis Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Multiple Sclerosis Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Multiple Sclerosis Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. AbbVie Inc.
12.1.2. Allergan PLC
12.1.3. AstraZeneca PLC
12.1.4. Bayer AG
12.1.5. Biogen Inc.
12.1.6. Eli Lilly and Company
12.1.7. F. Hoffmann-La Roche AG
12.1.8. GlaxoSmithKline PLC
12.1.9. Merck & Co. Inc.
12.1.10. Mylan N.V.
12.1.11. Novartis AG
12.1.12. Pfizer Inc.
12.1.13. Sanofi S.A.
12.1.14. Synthetic Biologics, Inc.
12.1.15. Teva Pharmaceuticals Industries Ltd.
12.2. Key Product Portfolio

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing



List of Figures

FIGURE 1. MULTIPLE SCLEROSIS MARKET RESEARCH PROCESS
FIGURE 2. MULTIPLE SCLEROSIS MARKET SIZE, 2023 VS 2030
FIGURE 3. MULTIPLE SCLEROSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. MULTIPLE SCLEROSIS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. MULTIPLE SCLEROSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. MULTIPLE SCLEROSIS MARKET DYNAMICS
FIGURE 7. MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2023 VS 2030 (%)
FIGURE 8. MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS MULTIPLE SCLEROSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS MULTIPLE SCLEROSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES MULTIPLE SCLEROSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES MULTIPLE SCLEROSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC MULTIPLE SCLEROSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC MULTIPLE SCLEROSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MULTIPLE SCLEROSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MULTIPLE SCLEROSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. MULTIPLE SCLEROSIS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. MULTIPLE SCLEROSIS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. MULTIPLE SCLEROSIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. MULTIPLE SCLEROSIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 6. MULTIPLE SCLEROSIS MARKET SIZE, BY INJECTABLE AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. MULTIPLE SCLEROSIS MARKET SIZE, BY ORAL AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 9. MULTIPLE SCLEROSIS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. MULTIPLE SCLEROSIS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. AMERICAS MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 12. AMERICAS MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 13. AMERICAS MULTIPLE SCLEROSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 14. ARGENTINA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 15. ARGENTINA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. BRAZIL MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 17. BRAZIL MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. CANADA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 19. CANADA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. MEXICO MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 21. MEXICO MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES MULTIPLE SCLEROSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 25. ASIA-PACIFIC MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 26. ASIA-PACIFIC MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. ASIA-PACIFIC MULTIPLE SCLEROSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 28. AUSTRALIA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 29. AUSTRALIA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. CHINA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 31. CHINA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. INDIA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 33. INDIA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. INDONESIA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 35. INDONESIA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. JAPAN MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 37. JAPAN MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. MALAYSIA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 39. MALAYSIA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. PHILIPPINES MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 41. PHILIPPINES MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. SINGAPORE MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 43. SINGAPORE MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. SOUTH KOREA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 45. SOUTH KOREA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. TAIWAN MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 47. TAIWAN MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. THAILAND MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 49. THAILAND MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. VIETNAM MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 51. VIETNAM MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA MULTIPLE SCLEROSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. DENMARK MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 56. DENMARK MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. EGYPT MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 58. EGYPT MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. FINLAND MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 60. FINLAND MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. FRANCE MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 62. FRANCE MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. GERMANY MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 64. GERMANY MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. ISRAEL MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 66. ISRAEL MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. ITALY MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 68. ITALY MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. NETHERLANDS MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 70. NETHERLANDS MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. NIGERIA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 72. NIGERIA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. NORWAY MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 74. NORWAY MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. POLAND MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 76. POLAND MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. QATAR MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 78. QATAR MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. RUSSIA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. SAUDI ARABIA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 82. SAUDI ARABIA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. SOUTH AFRICA MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 84. SOUTH AFRICA MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. SPAIN MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 86. SPAIN MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. SWEDEN MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 88. SWEDEN MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. SWITZERLAND MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 90. SWITZERLAND MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. TURKEY MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 92. TURKEY MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. UNITED ARAB EMIRATES MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM MULTIPLE SCLEROSIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM MULTIPLE SCLEROSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. MULTIPLE SCLEROSIS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 98. MULTIPLE SCLEROSIS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 99. MULTIPLE SCLEROSIS MARKET LICENSE & PRICING